Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer

Phase I trial to study the effectiveness of radiolabeled monoclonal antibody therapy in treating patients who have recurrent or persistent metastatic colorectal cancer. Radiolabeled monoclonal antibodies can locate tumor cells and deliver tumor-killing substances to them without harming normal cells. Radiolabeled monoclonal antibody therapy may be effective treatment for colorectal cancer

本I期临床试验旨在探究放射性标记单克隆抗体（radiolabeled monoclonal antibody）疗法治疗复发或持续性转移性结直肠癌患者的有效性。放射性标记单克隆抗体可定位肿瘤细胞，并向其递送杀瘤物质，同时不会对正常细胞造成损伤。该放射性标记单克隆抗体疗法或可成为结直肠癌的有效治疗手段。